Kantarjian H - Search Results

1

The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia.

Alfayez M, Issa GC, Patel KP, Wang F, Wang X, Short NJ, Cortes JE, Kadia T, Ravandi F, Pierce S, Assi R, Garcia-Manero G, DiNardo CD, Daver N, Pemmaraju N, Kantarjian H, Borthakur G. Alfayez M, et al. Among authors: kantarjian h. Leukemia. 2021 Mar;35(3):691-700. doi: 10.1038/s41375-020-0920-z. Epub 2020 Jun 19. Leukemia. 2021. PMID: 32561839

2

Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.

Keating MJ, Estey E, Kantarjian H, Plunkett W, O'Brien S, Koller C, Beran M, Freireich EJ. Keating MJ, et al. Among authors: kantarjian h. Leukemia. 1992;6 Suppl 2:78-80. Leukemia. 1992. PMID: 1578950 Review. No abstract available.

3

Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction.

Dhingra K, Kurzrock R, Kantarjian H, Baine R, Eastman PS, Ku S, Gutterman JU, Talpaz M. Dhingra K, et al. Among authors: kantarjian h. Leukemia. 1992 Aug;6(8):754-60. Leukemia. 1992. PMID: 1640725

4

Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia.

O'Brien S, Kantarjian H, Estey E, Koller C, Beran M, McCredie K, Keating M. O'Brien S, et al. Among authors: kantarjian h. Cancer. 1991 Aug 15;68(4):691-4. doi: 10.1002/1097-0142(19910815)68:4<691::aid-cncr2820680404>3.0.co;2-z. Cancer. 1991. PMID: 1855168

5

Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.

Dhingra K, Talpaz M, Kantarjian H, Ku S, Rothberg J, Gutterman JU, Kurzrock R. Dhingra K, et al. Among authors: kantarjian h. Leukemia. 1991 Mar;5(3):191-5. Leukemia. 1991. PMID: 2013978

6

RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.

Hirsch-Ginsberg C, LeMaistre AC, Kantarjian H, Talpaz M, Cork A, Freireich EJ, Trujillo JM, Lee MS, Stass SA. Hirsch-Ginsberg C, et al. Among authors: kantarjian h. Blood. 1990 Sep 15;76(6):1214-9. Blood. 1990. PMID: 2205309 Free article.

7

Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon.

Beran M, Andersson B, Kantarjian H, Keating M, Rios A, McCredie KB, Freireich EJ, Gutterman J. Beran M, et al. Among authors: kantarjian h. Leukemia. 1987 Jan;1(1):52-7. Leukemia. 1987. PMID: 2444829

8

Response to salvage therapy and survival after relapse in acute myelogenous leukemia.

Keating MJ, Kantarjian H, Smith TL, Estey E, Walters R, Andersson B, Beran M, McCredie KB, Freireich EJ. Keating MJ, et al. Among authors: kantarjian h. J Clin Oncol. 1989 Aug;7(8):1071-80. doi: 10.1200/JCO.1989.7.8.1071. J Clin Oncol. 1989. PMID: 2666590

9

Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.

Keating MJ, Smith TL, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ. Keating MJ, et al. Among authors: kantarjian h. Leukemia. 1988 Jul;2(7):403-12. Leukemia. 1988. PMID: 3164797

10

Cytogenetic association and prognostic significance of bone marrow blast cell terminal transferase in patients with acute myeloblastic leukemia.

Schachner J, Kantarjian H, Dalton W, McCredie K, Keating M, Freireich EJ. Schachner J, et al. Among authors: kantarjian h. Leukemia. 1988 Oct;2(10):667-71. Leukemia. 1988. PMID: 3172842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,496 results

Search Page